Welcome to LookChem.com Sign In|Join Free

CAS

  • or

31676-54-7

Post Buying Request

31676-54-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

31676-54-7 Usage

General Description

5-PHENYL-PYRIDIN-3-YLAMINE, also known as 5-Phenylpyridin-3-ylamine or 5-(Pyridin-3-yl)aniline, is a chemical compound with the molecular formula C11H10N2. It is a yellowish powder that is used in the synthesis of pharmaceutical products and organic compounds. As an aromatic amine, it is used as a building block for the production of various drugs and agrochemicals. This chemical is also used in the development of new materials and in research laboratories as a reagent for chemical reactions. Furthermore, it is important to handle 5-PHENYL-PYRIDIN-3-YLAMINE with caution as it may cause skin and eye irritation, and should be stored and used in a well-ventilated area.

Check Digit Verification of cas no

The CAS Registry Mumber 31676-54-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,6,7 and 6 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 31676-54:
(7*3)+(6*1)+(5*6)+(4*7)+(3*6)+(2*5)+(1*4)=117
117 % 10 = 7
So 31676-54-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H10N2/c12-11-6-10(7-13-8-11)9-4-2-1-3-5-9/h1-8H,12H2

31676-54-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-phenylpyridin-3-amine

1.2 Other means of identification

Product number -
Other names 5-PHENYL-PYRIDIN-3-YLAMINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:31676-54-7 SDS

31676-54-7Relevant articles and documents

UREA DERIVATIVES AS CB1 ALLOSTERIC MODULATORS

-

Page/Page column 61; 62, (2021/01/23)

Heteroaryl and aliphatic analogs of diarylurea-based cannabinoid 1 receptor (CB1 R) allosteric modulators of formula (I) are described. Exemplary analogs can provide improved potencies and pharmacokinetic properties. Methods of using the analogs to treat

Discovery of a potent, cell penetrant, and selective p300/CBP-associated factor (PCAF)/general control nonderepressible 5 (GCN5) bromodomain chemical probe

Humphreys, Philip G.,Bamborough, Paul,Chung, Chun-Wa,Craggs, Peter D.,Gordon, Laurie,Grandi, Paola,Hayhow, Thomas G.,Hussain, Jameed,Jones, Katherine L.,Lindon, Matthew,Michon, Anne-Marie,Renaux, Jessica F.,Suckling, Colin J.,Tough, David F.,Prinjha, Rab K.

supporting information, p. 695 - 709 (2017/02/05)

P300/CREB binding protein associated factor (PCAF/KAT2B) and general control nonderepressible 5 (GCN5/KAT2A) are multidomain proteins that have been implicated in retroviral infection, inflammation pathways, and cancer development. However, outside of viral replication, little is known about the dependence of these effects on the C-terminal bromodomain. Herein, we report GSK4027 as a chemical probe for the PCAF/GCN5 bromodomain, together with GSK4028 as an enantiomeric negative control. The probe was optimized from a weakly potent, nonselective pyridazinone hit to deliver high potency for the PCAF/GCN5 bromodomain, high solubility, cellular target engagement, and ≥18000-fold selectivity over the BET family, together with ≥70-fold selectivity over the wider bromodomain families.

Α 7 as intranuclear hydroxynicotinic acetylcholine receptor quinuclidines compd.

-

Paragraph 0271; 0272, (2018/10/03)

PROBLEM TO BE SOLVED: To provide ligands for the nicotinic α-7 receptor used for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.SOLUTION: The disclosure provides compounds of the specified formula I, including their salts, and compositions and methods using the compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 31676-54-7